Physician profile
Daniel Martin
NPI 1710092275
$1,013.76
in general payments reported to CMS, 2019-2025
26 companies · $23.25 in 2025
The $23.25 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $190 · 2021: $155 · 2022: $155 · 2023: $134 · 2024: $51.90 · 2025: $23.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $209.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $209.23 | 2020-2023 | Mako, Insignia |
| Ferring Pharmaceuticals INC. | $97.25 | 2019-2022 | |
| Pacira Therapeutics, INC. | $64.83 | 2020-2021 | |
| Heraeus Medical, LLC. | $53.45 | 2023 | Palacos |
| Smith+Nephew, INC. | $46.89 | 2019 | |
| Elite Orthopedics, LLC | $40.93 | 2021 | |
| Convatec INC. | $38.88 | 2019-2021 | |
| Horizon Therapeutics Plc | $37.81 | 2019-2020 | |
| Kci USA, INC. | $37.24 | 2021-2022 | |
| Depuy Synthes Sales INC. | $36.65 | 2019-2023 | Orthovisc |
| Fidia Pharma USA INC. | $36.64 | 2019-2024 | Hymovis |
| Ethicon US, LLC | $34.72 | 2019 | |
| Highridge Medical LLC | $34.30 | 2024 | Biomet Ebi Bone Healing System |
| Zimvie INC. | $27.82 | 2022-2023 | |
| Bioventus LLC | $25.60 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $24.11 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $23.25 | 2025 | |
| Medacta USA, INC. | $22.70 | 2021 | |
| Medtronic USA, INC. | $18.76 | 2019 | |
| Alexion Pharmaceuticals, INC. | $17.00 | 2022 | |
| Zimmer Biomet Holdings, INC. | $16.93 | 2019 | |
| Assertio Therapeutics, INC. | $15.85 | 2020 | |
| Amgen INC. | $14.05 | 2023 | Prolia, Evenity |
| Arteriocyte Medical Systems, INC. | $13.56 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.32 | 2019 | |
| Abbott Laboratories | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.